Xiaoyan Feng
State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Science And Peking Union Medical College
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 19, 2016
Clinical characteristics and survival of newly diagnosed multiple myeloma patients under 40 years old from single center and literature review
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: December 04, 2015
Detection of serum DKK1 in multiple myeloma and myeloma bone disease
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 15, 2015
The impact of renal function on prognostic value of β₂-microglobulin of ISS stage system in multiple myeloma patients--Clinical data analysis of 666 patients in a single center
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: June 03, 2015
Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China.
Journal: BMC cancer
Published: February 10, 2015
The impact of clone size on the prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 07, 2014
Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment.
Journal: Experimental hematology
Published: June 16, 2014
Last Updated: 09/26/2026